McClarren Financial Advisors Inc. raised its holdings in shares of The Procter & Gamble Company (NYSE:PG – Get Rating) by 23.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,878 shares of the company’s stock after purchasing an additional 737 shares during the period. McClarren Financial Advisors Inc.’s holdings in Procter & Gamble were worth $587,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in PG. Newbridge Financial Services Group Inc. lifted its holdings in Procter & Gamble by 1.8% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 3,824 shares of the company’s stock worth $580,000 after purchasing an additional 69 shares in the last quarter. Calton & Associates Inc. lifted its holdings in Procter & Gamble by 2.0% in the 4th quarter. Calton & Associates Inc. now owns 3,536 shares of the company’s stock worth $536,000 after purchasing an additional 71 shares in the last quarter. Bourgeon Capital Management LLC lifted its holdings in Procter & Gamble by 39.9% in the 4th quarter. Bourgeon Capital Management LLC now owns 249 shares of the company’s stock worth $38,000 after purchasing an additional 71 shares in the last quarter. Wescott Financial Advisory Group LLC lifted its holdings in Procter & Gamble by 0.3% in the 1st quarter. Wescott Financial Advisory Group LLC now owns 22,385 shares of the company’s stock worth $3,420,000 after purchasing an additional 72 shares in the last quarter. Finally, E Fund Management Co. Ltd. lifted its holdings in Procter & Gamble by 1.6% in the 3rd quarter. E Fund Management Co. Ltd. now owns 4,839 shares of the company’s stock worth $611,000 after purchasing an additional 75 shares in the last quarter. 62.13% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Stock Up 0.5 %
NYSE:PG opened at $151.77 on Friday. The firm has a market capitalization of $358.05 billion, a P/E ratio of 26.63, a PEG ratio of 4.21 and a beta of 0.41. The Procter & Gamble Company has a 1-year low of $122.18 and a 1-year high of $164.90. The company’s fifty day moving average price is $142.65 and its 200-day moving average price is $141.95. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.56 and a quick ratio of 0.37.
Procter & Gamble Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, May 15th. Investors of record on Friday, April 21st will be issued a dividend of $0.9407 per share. The ex-dividend date of this dividend is Thursday, April 20th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.76 dividend on an annualized basis and a yield of 2.48%. Procter & Gamble’s dividend payout ratio is 64.04%.
Insider Buying and Selling
In related news, CFO Andre Schulten sold 1,311 shares of the stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $137.34, for a total transaction of $180,052.74. Following the sale, the chief financial officer now directly owns 35,142 shares of the company’s stock, valued at $4,826,402.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Andre Schulten sold 1,311 shares of the stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $137.34, for a total transaction of $180,052.74. Following the sale, the chief financial officer now directly owns 35,142 shares of the company’s stock, valued at $4,826,402.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Susan Street Whaley sold 709 shares of the stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $137.34, for a total transaction of $97,374.06. Following the sale, the insider now directly owns 10,198 shares in the company, valued at $1,400,593.32. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,766 shares of company stock valued at $656,511. Corporate insiders own 0.26% of the company’s stock.
Analyst Ratings Changes
A number of research analysts recently commented on the company. Stifel Nicolaus boosted their price target on Procter & Gamble from $139.00 to $147.00 and gave the stock a “hold” rating in a report on Friday, January 20th. Wells Fargo & Company reduced their price objective on Procter & Gamble from $168.00 to $162.00 and set an “overweight” rating on the stock in a research note on Friday, January 20th. JPMorgan Chase & Co. raised Procter & Gamble from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $150.00 to $155.00 in a research note on Friday, March 3rd. Barclays cut their target price on Procter & Gamble from $161.00 to $158.00 and set an “overweight” rating on the stock in a research report on Monday, January 23rd. Finally, StockNews.com assumed coverage on Procter & Gamble in a research report on Thursday, March 16th. They issued a “hold” rating on the stock. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $156.00.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Get a free copy of the StockNews.com research report on Procter & Gamble (PG)
- Delta Airlines Is Ready To Fly Higher
- Global Payments Climbs After Goldman Sachs Upgrade
- Fastenal Is At A Critical Turning Point
- 3 Healthcare Stocks Insiders Are Buying
- Novo Nordisk Charges Higher and Could be Just Getting Started
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Get Rating).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.